Alpha-9 Oncology Inc, a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, announced an oversubscribed $175 million Series...
Nusano Inc, a physics company transforming the production of medical radioisotopes, and PharmaLogic Holdings Corp., a leading radiopharmaceutical contract development and manufacturing organization ("CDMO"),...
FogPharma®, a clinical-stage biopharmaceutical company dedicated to delivering a new class of therapies that go beyond the limits of currently available medicines using its...
